Progesterone Receptor Regulates Bcl-2 Gene Expression through Direct Binding to Its Promoter Region in Uterine Leiomyoma Cells
Author(s) -
Ping Yin,
Zhihong Lin,
You-Hong Cheng,
Erica E. Marsh,
Hiroki Utsunomiya,
Hiroshi Ishikawa,
Qing Xue,
Scott Reierstad,
Joy Innes,
Stephen Thung,
Julie Kim,
Eugene Yujun Xu,
Serdar E. Bulun
Publication year - 2007
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2007-0725
Subject(s) - progesterone receptor , endocrinology , medicine , biology , chromatin immunoprecipitation , receptor , transfection , leiomyoma , apoptosis , gene expression , cell culture , promoter , gene , estrogen receptor , biochemistry , genetics , surgery , cancer , breast cancer
Uterine leiomyomas are smooth muscle cell tumors that cause irregular uterine bleeding and pregnancy loss in many reproductive-age women. Progesterone stimulates their growth, whereas treatment with progesterone receptor (PR) antagonists or selective progesterone receptor modulators shrinks these tumors. Molecular mechanisms underlying these observations are unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom